US Orthopedic Biomaterials Market Examined by iData Research in In-demand Report Now Available at MarketPublishers.com

Posted: February 4, 2015 at 1:48 am

London, UK (PRWEB) February 03, 2015

Over the next few years, the stem cells market is poised to continue to be the most rapidly growing segment, which includes the segments for concentrated bone marrow and stem cell bone grafts. Stem cells provide greater osteogenesis and osteoinductive properties than other bone grafts, and thus enhance bone repair. To date, their usage is only considered for the treatment of spine cord injuries, but the market is likely to witness further expansion in case other indications are approved, such as with the foot where a number of patients may experience poor vascularisation.

The orthopedic biomaterials market in the USA is forecast to gain traction through 2021. The ageing population is a key factor driving the market. In tandem with the surging ageing population, the incidence rates of osteoarthritis and other types of degenerative disorders are also expected to grow, thus driving the demand for orthopedic biomaterials. Additionally, a huge portion of the overall biomaterial products market is engaged in treating soft tissue injuries, and most of them are sport-related. However, high costs of the development of some products could hinder the sectors growth. Furthermore, the timeliness of a products final approval is often hard to foretell.

Medtronic dominated the orthopedic biomaterials market as of 2014, due to the lions share of the bone graft substitute sector. The company announced in June 2014 its intention to buy Covidien for USD 42.9 billion.

In-demand study U.S. Orthopedic Biomaterials Market worked out by iData Research has been recently published at MarketPublishers.com.

Report Details:

Title: U.S. Orthopedic Biomaterials Market Published: January, 2015 Pages: 288 Price: US$ 6,995.00 http://marketpublishers.com/report/medical_devices/orthopedic/us-orthopedic-biomaterials-market.html

The research report contains an all-encompassing analysis and forecast of the orthopedic biomaterials market across the USA up to 2021. It provides detailed market analyses of leading market segments, including bone graft substitutes, hyaluronic acid viscosupplementation, orthopedic stem cells, growth factors, cartilage repair, cell therapy, and machined bone allografts; the categories are further subdivided into subcategories by various parameters. The study identifies the game-changing opportunities and potential hazards in the market, traces the key trends and technologies expected to impact the overall market and each of its individual segments in the years to come, as well as sheds light on the market drivers and restraints. Essential information on the number of procedures is provided. Furthermore, the research study canvasses the competitive landscape as well as discusses the top 22 companies along with their success strategies, M&As, etc.

Report Scope:

More in-demand reports by the publisher can be found at iData Research page.

Continued here:
US Orthopedic Biomaterials Market Examined by iData Research in In-demand Report Now Available at MarketPublishers.com

Related Post

Comments are closed.

Archives